House Oversight Subcommittee on Health Care Chair McClain to Hold Hearing on FDA Refusal to Regulate Hemp, CBD Products
July 21, 2023
July 21, 2023
WASHINGTON, July 21 -- Rep. Lisa McClain, R-Michigan, chairman of the House Oversight and Accountability Subcommittee on Health Care and Financial Services, issued the following news release on July 20, 2023:
Subcommittee on Health Care and Financial Services Chairwoman Lisa McClain (R-Mich.) today announced a hearing titled "Hemp in the Modern World: The Yearslong Wait for FDA Action" to examine the Food and Drug Administration (FDA)'s failure to regulate hemp-derived and . . .
Subcommittee on Health Care and Financial Services Chairwoman Lisa McClain (R-Mich.) today announced a hearing titled "Hemp in the Modern World: The Yearslong Wait for FDA Action" to examine the Food and Drug Administration (FDA)'s failure to regulate hemp-derived and . . .